Dilip S. Shanghvi has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
SPARC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dilip S. Shanghvi, the promoter of Sun Pharma Advanced Research Company (SPARC), has submitted a disclosure to the stock exchange under Regulation 31(4) of SEBI's Substantial Acquisition of Shares and Takeovers (SAST) Regulations, 2011. This regulation requires persons holding 5% or more of a company's shares to make specific disclosures about changes in their shareholding. The headline does not provide details on whether the disclosure involves an increase, decrease, or a threshold-related event. Without the actual disclosure document or further details, the exact nature and size of the shareholding change cannot be determined from this announcement.
This is a routine regulatory filing and does not, on its own, indicate any material change in the promoter's stake. Investors should wait for the actual disclosure document to know whether this represents a buy, sell, or threshold-crossing event before drawing conclusions about shareholding movement.